Colgate director gets 209-share stock grant

COLGATE PALMOLIVE CO director Brian Newman reported a routine compensation-related equity grant.

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO director Brian Newman reported a routine compensation-related equity grant. He acquired 209 shares of common stock at $89.45 per share as a grant or award, representing a portion of his annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors.

Following this grant, Newman directly holds 7,831 shares of Colgate-Palmolive common stock. He is also shown with indirect ownership of 36 shares held by a family trust. These entries reflect compensation and holding disclosures rather than open-market buying or selling.

Insider Trade Summary

Grant/Award: 209 shares

Grant/Award 2 txns

Insider Newman Brian

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	209	$89.45	$19K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,831 shares (Direct); Common Stock — 36 shares (Indirect, By Family Trust)

Footnotes (1)

1. F1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Stock grant size: 209 shares Grant valuation price: $89.45 per share Direct holdings after grant: 7,831 shares +1 more

4 metrics

Stock grant size 209 shares Grant, award, or other acquisition of common stock

Grant valuation price $89.45 per share Value used for the 209-share compensation grant

Direct holdings after grant 7,831 shares Common stock held directly following the transaction

Indirect family trust holdings 36 shares Common stock held indirectly by family trust

Key Terms

Deferred Compensation Plan for Non-Employee Directors, annual cash retainer, stock unit account, indirect ownership

4 terms

Deferred Compensation Plan for Non-Employee Directors financial

"pursuant to the Deferred Compensation Plan for Non-Employee Directors"

annual cash retainer financial

"Portion of annual cash retainer deferred to a stock unit account"

stock unit account financial

"deferred to a stock unit account pursuant to the Deferred Compensation Plan"

indirect ownership financial

"Common Stock ... indirect ... nature_of_ownership: By Family Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Colgate-Palmolive (CL) director Brian Newman report?

Brian Newman reported receiving 209 shares of Colgate-Palmolive common stock as a grant or award. The shares relate to a portion of his annual cash retainer deferred into a stock unit account under the company’s Deferred Compensation Plan for Non-Employee Directors.

At what price was Brian Newman’s Colgate-Palmolive stock grant recorded?

The 209-share stock grant for Brian Newman was recorded at $89.45 per share. This reflects the value used for the compensation-related award under Colgate-Palmolive’s Deferred Compensation Plan for Non-Employee Directors, not an open-market purchase price.

How many Colgate-Palmolive shares does Brian Newman hold after this Form 4?

After the reported grant, Brian Newman directly holds 7,831 shares of Colgate-Palmolive common stock. In addition, the filing shows indirect ownership of 36 shares held by a family trust, giving investors a clearer view of his overall reported equity position.

Is Brian Newman’s Colgate-Palmolive transaction an open-market buy or a compensation grant?

The transaction is a compensation grant, not an open-market purchase. It is coded as a grant, award, or other acquisition and is described as a portion of his annual cash retainer deferred into a stock unit account under a deferred compensation plan for non-employee directors.

What plan governs Brian Newman’s deferred Colgate-Palmolive stock units?

The deferred stock units are governed by Colgate-Palmolive’s Deferred Compensation Plan for Non-Employee Directors. The filing notes that a portion of his annual cash retainer was deferred into a stock unit account under this plan, resulting in the 209-share grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newman Brian

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		209	A	$89.45	7,831	D
Common Stock								36	I	By Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

	/s/ Kristine Hutchinson, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)